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RESEARCH ARTICLE
PRETERM LABOR

The transient receptor potential vanilloid 4 channel
modulates uterine tone during pregnancy
Lihua Ying,1 Margaux Becard,2 Deirdre Lyell,3 Xiaoyuan Han,4 Linda Shortliffe,4
Cristiana Iosef Husted,5 Cristina M. Alvira,1,6* David N. Cornfield1,6,7*†

INTRODUCTION
In mammalian biology, the uterus must first remain quiescent to accommodate a growing organism in utero, and then contract powerfully to expel
the mature fetus for relatively independent air-breathing life. Despite the
clear importance of these divergent but biologically imperative uterine
roles, the mechanisms regulating the switch between the myometrial
quiescence of pregnancy and the myometrial contraction of labor are
largely unknown. The importance of gaining insight into the mechanisms
that underlie the dual role of the myometrium is highlighted by the lack
of effective strategies to either prevent or treat preterm labor, a substantial
cause of perinatal mortality and morbidity (1, 2).
The physiologic signals that underlie the rhythmic, repeated uterine
contractions that characterize labor remain incompletely understood.
Among the theories related to the onset of labor are changes in myometrial
progesterone and estrogen receptors (3), or the release of amniotic fluid
from the amnion (4). Moreover, in most mammalian species, progesterone
withdrawal seems to play a central role in the onset of labor (5).
Current evidence suggests that myometrial smooth muscle cell (mSMC)
Ca2+ homeostasis is modulated near term to promote uterine contractility.
In the human myometrium, entry of extracellular Ca2+ is essential for the
initiation and maintenance of spontaneous and agonist-induced rhythmic
contractions (6, 7). Binding of oxytocin to the oxytocin receptors promotes
1
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uterine contractility by increasing receptor-mediated calcium (Ca2+) entry
(8). Although the current paradigm suggests that extracellular Ca2+ enters
mSMC predominantly via L-type voltage-gated calcium channels (9),
L-type Ca2+ channel blockers tested in clinical trials for the prevention
of preterm labor have neither prolonged gestation nor improved adverse
perinatal outcomes, owing in part to dose-related side effects (2, 10). The
absence of a definitive therapeutic benefit with L-type Ca2+ channel blockade suggests that Ca2+ may also enter the myometrium through an
alternative route.
Thus, we considered whether Ca2+ might gain entry into the mSMC
via transient receptor potential vanilloid (TRPV) channels. TRPV channels
belong to the vanilloid subfamily of the TRP channel family, a group of
nonselective cation channels permeable to sodium, Ca2+, and magnesium.
TRPV channels are widely expressed in the central and peripheral nervous
system, epithelial cells, vascular smooth muscle cells (11), and other
mesenchyme-derived cells (12). In particular, the TRPV4 channel is activated in response to cell swelling, shear stress, moderate heating, hypotonic
stress (13), and phorbol ester (14). Mice lacking TRPV4 are less sensitive
to osmotic stress and noxious mechanical and painful stimuli (15).
Although TRPV4 is expressed in the murine uterus (16), TRPV4-null
mice seem to reproduce normally. However, whether these mice are resistant to stimuli known to induce preterm labor remains entirely unknown.
To determine whether the TRPV4 channel might play a role in uterine
contractility, we undertook a series of experiments in rats, mice, and
humans. We demonstrated that TRPV4 channel gene and protein expression increases with gestation, proportionally more in the membrane
relative to the whole cell. We also demonstrated that TRPV4 expression
is greater in uterine tissue of pregnant, compared to nonpregnant,
women. Moreover, we used microfluorimetry, myography, and collagen
gel contraction assays to demonstrate a role for the TRPV4 channel in
oxytocin-induced increases of mSMC cytosolic calcium and uterine
contraction. As further proof of principle, we used murine models of
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The importance of gaining insight into the mechanisms underlying uterine quiescence and contractility is highlighted by
the absence of an effective strategy to prevent or treat preterm labor, the greatest cause of perinatal mortality and
morbidity worldwide. Although current evidence suggests that in myometrial smooth muscle cells (mSMCs) calcium
homeostasis is modulated near term to promote uterine contractility, the efficacy of blocking voltage-operated calcium
channels is limited by dose-related cardiovascular side effects. Thus, we considered whether uterine contractility might be
modulated by calcium entry via transient receptor potential vanilloid 4 (TRPV4) channels. In mSMC, TRPV4 gene and
protein expression increased with gestation, and TRPV4-mediated Ca2+ entry and contractility were increased in mSMC
from pregnant compared to nonpregnant rats. Cell membrane TRPV4 expression was specifically increased, whereas
the expression of b-arrestin-1 and b-arrestin-2, molecules that can sequester TRPV4 in the cytoplasm, decreased.
Physical interaction of b-arrestin-2 and TRPV4 was apparent in nonpregnant, but absent in pregnant, mouse uterus.
Moreover, direct pharmacologic activation of TRPV4 increased uterine contraction, but oxytocin-induced myometrial
contraction was blocked by pharmacologic inhibition of TRPV4 and decreased in mice with global deletion of TRPV4.
Finally, TRPV4 channel blockade prolonged pregnancy in two distinct in vivo murine models of preterm labor, whereas
the absence of either b-arrestin-1 or b-arrestin-2 increased susceptibility to preterm labor. These data suggest that TRPV4
channel activity modulates uterine contractility and might represent a therapeutic target to address preterm labor.

RESEARCH ARTICLE

TRPV4 expression and membrane localization increase
during pregnancy
Among the TRPV channels, TRPV4 is activated by stretch, swelling, heat,
or pressure (17–19), physiologic stimuli that are likely to play a role in
uterine contractility. Thus, to determine whether TRPV4 channels
modulate myometrial tone during pregnancy, we used quantitative polymerase chain reaction (qPCR) to measure Trpv4 gene expression in
primary mSMCs obtained from rats under control conditions (nonpregnant), at specific time points during pregnancy (D7 to D21) and
postpartum. During pregnancy, Trpv4 gene expression in mSMC

markedly increased (Fig. 1A). By day 14 of gestation, Trpv4 gene expression
in pregnant mSMC was more than sixfold greater than in nonpregnant
mSMC (white bar) and remained elevated throughout the remainder of
pregnancy. However, after parturition, Trpv4 expression decreased, with
postpartum expression no different than that found in nonpregnant mSMC.
We next determined whether a similar up-regulation of TRPV4 occurred in the uterus of pregnant women. In keeping with the results in
the pregnant rat, TRPV4 gene expression was almost 1000-fold greater in
pregnant compared to nonpregnant human uterine tissue (fig. S1). However, owing to limitations in sample procurement, the results must be
considered in light of the substantial difference (P < 0.001) in the mean
age of the pregnant women (33 ± 3 years) compared to nonpregnant
women (56 ± 4 years).
In pregnant rats, the increase in Trpv4 gene expression was associated
with an increase in TRPV4 protein expression. TRPV4 protein was about
1.5-fold higher in whole-cell lysates of mSMC obtained from pregnant

Fig. 1. TRPV4 expression and cell membrane localization increase
during late gestation. (A) Relative Trpv4 gene expression was determined
by qPCR in mSMC isolated from nonpregnant rats and rats at various stages
of pregnancy or postpartum (PP). n = 6 samples per group, with each sample
containing cells from at least three animals; **P = 0.0094 for D14, **P =
0.0087 for D17, **P = 0.0075 for D19, and **P = 0.01 D21 versus nonpregnant
(NP) via one-way analysis of variance (ANOVA). (B and C) Western immunoblot to detect TRPV4 protein in (B) whole-cell lysates and (C) membrane
fractions of myometrial SMC isolated from nonpregnant and pregnant

(D21) rats normalized to Coomassie staining. Quantification shown as bar
graphs on the right, expressed as fold increase in expression versus nonpregnant; n = 4 samples containing cells obtained from a total of 12 animals;
*P = 0.0286 for (B) and *P = 0.0265 for (C) via Mann-Whitney U test. (D) Immunocytochemistry of rat mSMC obtained from nonpregnant and D21 rats,
shown with the CellMask (Invitrogen) plasma membrane stain (red), 4′,6diamidino-2-phenylindole (DAPI) (blue), and a primary antibody to detect
TRPV4 (green), with the presence of TRPV4 on the plasma membrane evidenced by the colocalization signal (yellow). Scale bar, 50 mm.

preterm labor to show that pharmacologic blockade of the TRPV4
channel can effectively prolong pregnancy.

RESULTS
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rats at day 21 of gestation (D21) compared to nonpregnant mSMC
(Fig. 1B). Notably, TRPV4 protein was fivefold higher in the membrane
fraction of the pregnant versus nonpregnant mSMC (Fig. 1C), suggesting
that changes in both TRPV4 expression and subcellular localization occur
during pregnancy. To further evaluate whether the cell membrane expression of TRPV4 in mSMC changes during gestation, mSMCs from pregnant
and nonpregnant rats were immunostained to detect the presence of
TRPV4 protein in combination with a plasma membrane selective dye.
With this method, the overall intensity of TRPV4 membrane staining
was higher in the cells from pregnant rats (Fig. 1D), consistent with increased expression of TRPV4 protein expression noted in the membrane
fraction. Together, these data suggest that during pregnancy, increases in
TRPV4 expression in combination with a putative increase in TRPV4
channel trafficking to the plasma membrane may facilitate enhanced
activation of the channel during parturition (20, 21).

The expression of b-arrestin proteins and their physical
interaction with TRPV4 decrease during pregnancy
Dynamic protein-protein interactions can modify ion channel activity
through subcellular trafficking. For example, TRPV4 can interact with barrestins (21), a family of proteins that functionally down-regulate transmembrane receptors by enhancing receptor internalization via endocytosis
(21, 24). In vascular SMC, b-arrestin-1 and b-arrestin-2 can modulate
TRPV4 activity via ubiquitination and subsequent endocytosis (25).
To further detail the intracellular movement of TRPV4 during pregnancy, we evaluated frozen sections of uterine tissue from nonpregnant
and pregnant mice by confocal microscopy. TRPV4 was present in cells
and tissue in both pregnant and nonpregnant mice (Fig. 3A). However,
in images of samples derived from pregnant mice, the TRPV4 staining
was much more intense at the membrane and with a linear orientation
and radial distribution, as compared with the images from the nonpregnant
mice, where TRPV4 staining was more diffuse, nonlinear, and distributed
more centrally.
To more fully explore the hypothesis that trafficking of TRPV4 is
altered in mSMC during pregnancy, we investigated whether the increased
membrane expression of TRPV4 in pregnant mSMC was associated with
changes in b-arrestin-1 or b-arrestin-2 expression. Protein expression of
both b-arrestin-1 and b-arrestin-2 appeared to be decreased in mSMC

Fig. 2. TRPV channel activation increases cytosolic calcium in pregnant
more than nonpregnant mSMC. (A) mSMCs from nonpregnant (gray) and
D21 (black) rats were loaded with fura-2, and the apparent cytosolic calcium
(R/R0) was measured at baseline and after the addition of the TRPV channel
agonist, 4aPDD (arrow). (B) Peak cytosolic calcium (R/R0) in nonpregnant and
D21 mSMC; n = 52 to 86 cells and **P = 0.0012 via Mann-Whitney U test.
(C) mSMCs from D21 pregnant (P) rats were loaded with fura-2, and the R/R0
induced by 4aPDD in cells pretreated with the TRPV blocker ruthenium red
(RR) was compared to cells treated with 4aPDD alone. (D) Peak cytosolic
calcium (R/R0) in D21 mSMC treated with 4aPDD and either vehicle or ruthenium
red; n = 52 to 76 cells and ***P = 0.004 via Mann-Whitney U test. (E) mSMCs from
nonpregnant rats were loaded with fura-2, and the R/R0 induced by 4aPDD in
cells pretreated with the TRPV blocker ruthenium red was compared to cells
treated with 4aPDD alone. (F) Peak cytosolic calcium (R/R0) in nonpregnant
mSMC treated with 4aPDD and either vehicle or ruthenium red; n = 86 cells.

from pregnant (D19) as compared to nonpregnant mSMC (Fig. 3, B
and C), although the results did not reach statistical significance. This
finding suggested that decreases in b-arrestin-1 and b-arrestin-2 late in
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Activation of TRPV channels increases cytosolic calcium
more in mSMC from pregnant than nonpregnant rats
We evaluated the effect of TRPV channel activation on mSMC cytosolic
calcium ([Ca2+]i) with the calcium-sensitive fluorophore fura-2. Pharmacologic TRPV channel activation with the selective TRPV4 agonist 4aphorbol 12,13-didecanoate (4aPDD) (22) caused a sustained increase in
[Ca2+]i in mSMC from both pregnant and nonpregnant rats (Fig. 2A).
However, the maximal increase in [Ca2+]i was greater in pregnant
mSMC as compared to nonpregnant mSMC (**P = 0.0012; Fig. 2B).
In further experiments, pregnant mSMCs were pretreated with either
vehicle or the nonselective TRPV inhibitor ruthenium red (23) before
stimulation with 4aPDD. Ruthenium red completely blocked the 4aPDDinduced increase in [Ca2+]i in the pregnant cells (Fig. 2, C and D),
implying that in mSMC from pregnant rats, 4aPDD increases [Ca2+]i
via TRPV channel activation. In contrast, in nonpregnant mSMC (Fig.
2, E and F), the relatively smaller 4aPDD-induced increase in [Ca2+]i
was not attenuated by ruthenium red, suggesting that calcium increases
are primarily attributable to mechanisms other than TRPV channels in
nonpregnant mSMC.

RESEARCH ARTICLE
gestation may result in discrete, time-limited reductions in the ubiquitination and endocytosis of TRPV4, thereby allowing for functional increases in TRPV4 activity before parturition.
Previous work has shown that b-arrestin-2 can bind TRPV4 in vascular
SMC, thereby decreasing the amount of TRPV4 present at the cell membrane by increasing endocytosis (21). To evaluate whether TRPV4 physically interacts with b-arrestin-2, we next performed in situ PLAs, a
highly sensitive test that permits the detection of protein-protein interactions in nonmodified cells. As demonstrated in Fig. 3D, physical interaction between TRPV4 and b-arrestin-2 was present only in nonpregnant
mSMC, providing evidence for a role for b-arrestin-2 in maintaining the
TRPV4 channel within the cytosol in nonpregnant mSMC.

TRPV4 channel activity modulates uterine contractility
To test the hypothesis that TRPV4 channel activity modulates the uterine
contractile response to oxytocin, we studied the contractile response of
uterine muscle strips from pregnant (day 18) wild-type mice exposed to
increasing concentrations of oxytocin in the presence and absence of a
specific TRPV4 channel antagonist, HC 067047. Oxytocin induced a
dose-dependent increase in uterine contractility that was abrogated by
pharmacologic blockade of the TRPV4 channel (Fig. 5, A and B). Similarly, the TRPV4 agonist GSK1016790A also induced a dose-dependent
increase in uterine contractility (Fig. 5, C and D) that was blocked by
HC 067047. Finally, as further proof of concept that TRPV4 is a key
regulator of uterine contractility, the oxytocin-induced contractile response was markedly attenuated in uterine strips obtained from mice
containing global deletions in TRPV4 (Trpv4−/−) (Fig. 5, E and F).

Fig. 3. The expression of b-arrestin proteins and their physical interaction with TRPV4 decrease during pregnancy. (A) Confocal microscopy was performed on frozen myometrial tissue from both
pregnant and nonpregnant mice immunostained to detect TRPV4
(red). Scale bars, 100 mm. (B and C) Western blotting of myometrial
tissue from pregnant and nonpregnant mice to detect (B) b-arrestin1 (ARRB1) and (C) b-arrestin-2 (ARRB2), with b-actin as a loading control;
n = 3 and P = 0.10 for both (B) and (C) via Mann-Whitney U test. (D) In
situ proximity ligation assay (PLA) was performed on nonpregnant and
pregnant uterine tissue from wild-type (WT) and Arrb2−/− mice, with
physical interaction of TRPV4 and ARRB2 visualized by pink staining.
Tissue from Arrb2−/− mice was used as a negative control. Scale bar,
100 mm.

Pharmacologic blockade of TRPV4 delays parturition in
murine models of preterm labor
To determine whether these changes in TRPV4 expression and subcellular localization have meaningful physiologic implications during
pregnancy and parturition, we next performed experiments using a
selective TRPV4 channel antagonist in two established murine models
of preterm birth. First, we treated pregnant C57BL/6 mice with a single
subcutaneous injection of either vehicle or the progesterone receptor antagonist RU-486 at day 15 of gestation (D15). RU-486–treated mice were
then treated with either intraperitoneal injections of normal saline or one
or more doses of the selective TRPV4 channel antagonist HC 067047
beginning 8 hours after RU-486 administration (27). Control mice exposed to vehicle instead of RU-486 delivered pups, on average, 108 hours
after vehicle injection (Fig. 6A). In contrast, mice treated with RU-486
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TRPV4 activation mediates human mSMC contraction in
collagen gels
To assess the role of TRPV4 in mediating mSMC contraction, human
mSMCs were included in collagen gels (26) after silencing TRPV4 expression with small interfering RNA (siRNA). Transfection of the human
mSMC with anti-TRPV4 siRNA effectively depleted both TRPV4 mRNA
(Fig. 4A) and protein (Fig. 4B). Collagen gels without incorporated
mSMC did not contract in response to vehicle, oxytocin, or lipopolysaccharide (LPS). Collagen gels containing nontargeting control (NTC)
siRNA-treated SMC contracted slightly in the absence of stimuli. Stimulation
of gels containing NTC siRNA-treated mSMC with oxytocin (100 mM)
or an inflammatory stimulus (LPS, 100 ng/ml) decreased the collagen area
by 45 ± 2% (P = 0.022) and 41 ± 2% or (P = 0.1216), respectively (Fig. 4, C
and D). However, neither oxytocin nor LPS induced contraction in collagen gels containingTRPV4 siRNA-treated mSMC.

RESEARCH ARTICLE

Loss of either b-arrestin-1 or b-arrestin-2 heightens the
susceptibility to LPS-induced preterm labor
To further explore the mechanism whereby TRPV4 modulates uterine
tone, we evaluated whether mice with deletions of either b-arrestin1 (Arrb1−/−) or b-arrestin-2 (Arrb2−/−) demonstrated altered sensitivity
to the induction of preterm labor. We hypothesized that the Arrb1−/−
and Arrb2−/− mice would be highly susceptible to LPS-induced preterm
labor, and thus, we chose to perform studies with a lower dose of LPS
(1 mg/kg) than those used in our previous experiments. Treating wildtype mice at day 15 of pregnancy with this lower dose of LPS induced
delivery of pups at 58 ± 15 hours after injection (Fig. 6C). Loss of either
b-arrestin-1 or b-arrestin-2 markedly increased the susceptibility to
preterm labor, with the Arrb1−/− mice delivering pups at 15 ± 2 hours
after LPS injection, and Arrb2−/− mice delivering pups at 18 ± 1 hours
after LPS injection.

DISCUSSION

Fig. 4. Depletion of TRPV4 attenuates human mSMC contraction in
response to oxytocin. (A and B) Human mSMCs were transfected with
either NTC or TRPV4 siRNA, and TRPV4 gene (A) and protein (B) expression were determined. (C and D) Collagen gel contraction assays were
performed with human mSMC treated with NTC or TRPV4 siRNA and
stimulated with vehicle, oxytocin, or LPS. The collagen-covered area in
each well was compared to the area of the well containing collagen
alone and expressed as a percentage. §P = 0.022 for oxytocin-stimulated
and P = 0.1216 for LPS-stimulated NTC siRNA versus vehicle, and ****P <
0.0001 for both oxytocin- and LPS-stimulated TRPV4 siRNA gels versus
NTC siRNA gels, via two-way ANOVA; n = 3 to 6 for all groups.

Despite the clear importance of strategies to prevent preterm labor, limited
understanding surrounding the fundamental biology of uterine contractility
continues to constrain efforts to develop effective therapies. The present
report includes evidence that in mSMC, the TRPV4 channel plays a central
role in uterine contractility. By modulating channel activity in murine
models of preterm labor, we provide evidence that the TRPV4 channel
has meaningful therapeutic potential in the context of both physiologic
and pathophysiologic labor.
Consistent with a previous report (16), these data demonstrate that
mSMC, human and murine, express TRPV4 channels. Moreover,
TRPV4 expression in the uterus increases markedly in both rat and
mouse during pregnancy, and TRPV4 expression on the cell membrane
also increases. Our data also suggest that TRPV4 expression may
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and saline delivered pups only 15 ± 3 hours after RU-486 injection. Although a single large dose of HC 067047 prolonged the onset of labor in
the RU-486–treated mice to 27 ± 2 hours, this was not significantly different from the time until onset of labor in the RU-486 + saline–treated
mice. However, multiple smaller doses of the TRPV4 antagonist HC
067047 significantly prolonged onset until labor in the RU-486 mice,
with this group delivering pups at 63 ± 7 hours after RU-486 injection
(P = 0.0002).
Inflammation and infection are well-established causes of preterm
labor. Given the recent identification of TRPV4 as a proinflammatory
factor (28), we hypothesized that TRPV4 blockade may be even more
efficacious in an inflammatory model of preterm birth. The link between
inflammation and preterm labor has been recapitulated in an established
murine model of preterm labor induced by the administration of intraperitoneal LPS early in pregnancy (29). Pregnant mice received intraperitoneal injections of either phosphate-buffered saline (PBS) or LPS
on D15 of pregnancy, and 8 hours later, the groups of LPS-treated mice
received vehicle or either a single large dose or repeated smaller doses of
HC 067047. Pregnant mice receiving LPS and vehicle delivered pups
within 24 ± 1 hours (Fig. 6B). Although treatment with a single dose of
HC 067047 had no effect on the time until delivery, treatment with
multiple small doses of HC 067047 effectively prevented preterm labor
induced by LPS, prolonging the time until delivery of pups to 111 ±
8 hours, which was no different than control mice receiving vehicle in
the absence of LPS.

RESEARCH ARTICLE
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Fig. 5. TRPV4 channel activity modulates uterine contractility. (A) Myography of uterine muscle strips from pregnant WT mice at D18 was performed while incubating the strips with increasing doses of oxytocin in the
presence of vehicle (black circles), 200 nM HC 067047 (dark gray squares),
or 1 mM HC 067047 (light gray triangles). ****P < 0.0001 versus 1 × 10−10 M
oxytocin, §§P = 0.0086 for 200 nM HC 067047, and P = 0.022 for 1 mM HC
067047 versus 1 × 10−8 M oxytocin, §§P = 0.0235 for 200 nM HC 067047 and
P = 0.0034 for 1 mM HC 067047 versus 1 × 10−7 M oxytocin, §§§P = 0.0005 for
200 nM HC 067047, and P = 0.0002 for 1 mM HC 067047 versus 1 × 10−6 M
oxytocin via two-way ANOVA with n = 4 to 7. (B) Representative myography
tracings for each treatment group at baseline (left) and in response to 1 × 10−6 M
oxytocin (right). (C) Myography of uterine muscle strips from pregnant WT
mice at D18 was performed while incubating the strips with increasing doses
of the TRPV4 activator GSK1016790A in the presence of vehicle (black circles),

200 nM HC 067047 (dark gray squares), or 1 mM HC 067047 (light gray triangles).
**P = 0.0023 and ****P < 0.0001 versus 1 × 10−10 M GSK1016790A, §§P = 0.0056
for 200 nM HC 067047 and P = 0.0076 for 1 mM HC 067047 versus 1 × 10−7 M
GSK1016790A, and §§§§P < 0.0001 for 200 nM and 1 mM HC 067047 versus
1 × 10−6 M GSK1016790A via two-way ANOVA with n = 6 to 8. (D) Representative myography tracings for each treatment group at baseline (left)
and in response to 1 × 10−6 M GSK1016790A (right). (E) Myography of uterine
muscle strips from pregnant WT mice (black circles) and Trpv4−/− mice (dark gray
squares) at D18 was performed while incubating strips with increasing doses of
oxytocin. ****P < 0.0001 versus 1 × 10−10 M oxytocin, §P = 0.012 for Trpv4−/− versus
WT at 1 × 10−8 M oxytocin, §§§§P < 0.0001 for Trpv4−/− versus WT at 1 × 10−7 M
and 1 × 10−6 M oxytocin, and ## versusTrp4−/− mice at 1 × 10−10 M oxytocin via
two-way ANOVA with n = 4. (F) Representative myography tracings for each treatment group at baseline (left) and in response to 1 × 10−6 M oxytocin (right).
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Consistent with the notion that dynamic protein-protein interactions modulate TRPV channel activity in mSMC,
we identified a trend toward decreased
b-arrestin-1 and b-arrestin-2 expression
as pregnancy moves toward term, although
this finding will need to be confirmed in
larger data sets. Decreased b-arrestin-2 expression can augment the presence of
TRPV4 on the cell membrane TRPV4
(3, 21, 30). Both immunocytochemistry
and Western blot analysis of cell membrane fractions demonstrate an increase
in TRPV4 expression at the membrane
with pregnancy. Our confocal imaging
studies were consistent with this construct
because TRPV4 expression was more discrete and peripheral in tissue derived from
pregnant as opposed to nonpregnant
animals. Moreover, results obtained from
the PLA confirmed that TRPV4 physically
interacts with b-arrestin-2 in the nonpregnant uterus and that this interaction
is diminished during late pregnancy.
Although additional experiments are
needed to definitively link the increased
Fig. 6. TRPV4 inhibition protects against preterm labor, whereas loss of b-arrestin-1 or b-arrestin-2 membrane localization of TRPV4 in
increases susceptibility to preterm labor. (A) Pregnant WT mice at D15 were treated with RU-486 (150 mg) mSMC with decreases in b-arrestin expresintraperitoneally, and after 8 hours, groups were treated with vehicle, HC 067047 as a single dose (20 mg/kg), or sion during pregnancy, data from whole
multiple doses of HC 067047 (10 mg/kg) every 8 hours. The time until delivery of the first pup was recorded. ***P = animal studies provide further support for
0.0002 and ****P < 0.0001 versus vehicle, and §§§P = 0.008 versus RU-486 + HC 067047 (single) via one-way ANOVA
the overall notion, given that Arrb1−/− and
with n = 3 to 5 per group. (B) Pregnant WT mice at D15 were treated with LPS (3 mg/kg) intraperitoneally, and after
−/−
null pregnant mice were more
8 hours, groups were treated with vehicle, HC 067047 as a single dose (20 mg/kg), or multiple doses of HC 067047 Arrb2
sensitive
to LPS than wild-type control
(10 mg/kg) every 8 hours. The time until delivery of the first pup was recorded. ****P < 0.0001 versus vehicle
via one-way ANOVA with n = 3 to 6 per group. (C) Pregnant WT, Arrb1−/−, or Arrb2−/− mice were treated with mice. These data suggest that when bLPS (1 mg/kg) intraperitoneally, and the time until delivery of the first pup was recorded. ****P < 0.0001 arrestin molecules are absent, TRPV chanversus vehicle for each genotype, and §§P = 0.0018 and §§§§P < 0.0001 versus LPS WT, by two-way ANOVA nels are either more concentrated on the
with n = 4 per group.
mSMC membrane at an earlier point in
gestation or more abundant overall. Therefore, increased TRPV4 channel expression
increase in the human uterus during pregnancy. However, difficulties in on the mSMC membrane may underlie the increased sensitivity of the bthe procurement of uterine tissue from nonpregnant women of child- arrestin–null mice to inflammation-induced preterm labor.
Multiple lines of investigation offer support for this construct. Grotegut
bearing age resulted in differences in the mean ages of the two study
groups, thus limiting the conclusions that might be drawn regarding et al. demonstrated that uterine sensitivity to oxytocin, a molecule that
differential expression of TRPV4 during human pregnancy.
stimulates uterine contractility, is contingent upon b-arrestins. Specifically,
Recent data suggest that TRPV channel activity is modulated, in part, desensitization to oxytocin, which is associated with uterine contractile
by subcellular trafficking involving dynamic protein-protein interactions. dysfunction and cesarean section delivery, is mediated by b-arrestins
The TRPV4 channel is a specific interacting partner of b-arrestins (21), (31). Moreover, a functional link between TRPV4 and the b-arrestins
a family of proteins that functionally down-regulate G protein (hetero- has been demonstrated previously (21). These two molecules, together,
trimeric guanine nucleotide–binding protein) and other transmembrane can finely regulate intracellular Ca2+ signaling and prevent excessive inreceptors by inducing conformational changes that prevent receptor cou- creases in cytosolic calcium (21, 32). From an evolutionary perspective,
pling or by enhancing receptor internalization via endocytosis (21, 24). the juxtaposition of these molecules, superimposed on altered levels of
In vascular SMC, both b-arrestin-1 and b-arrestin-2 modulate TRPV4 expression during pregnancy, may represent a key component in the
activity and ubiquitination (21) via the binding and recruitment of atrophin puzzle of prolonged uterine quiescence during pregnancy punctuated
1–interacting protein 4 (AIP4), a member of the HECT homologous to by the high-tone, rhythmic contractions that characterize effective labor.
Data derived from two distinct murine models of preterm labor
E6-AP C-terminal family of ubiquitin ligases that is the relevant ligase
for TRPV4 channel ubiquitination (25). Consequently, the basal activity provided further proof of concept for a functional role for TRPV4
of TRPV4 might be constrained even in the absence of changes in in modulating myometrial contractility. Pregnancy was prolonged
by pharmacologic blockade of the TRPV4 channel. In the context
TRPV4 expression (25).

RESEARCH ARTICLE
Rat studies
We used timed-pregnant Sprague-Dawley rats obtained from Charles
River Laboratories. The experimental protocols were approved by the
Stanford University animal care and use committee. Rats were housed
in a 25°C temperature room with alternating 12-hour light and dark
cycles. Day 0 of pregnancy was determined by observation of the vaginal plug. Rats generally delivered on the morning of day 22.
Animals were anesthetized with 2% isoflurane and euthanized by
exsanguination. Subsequently, uterine tissue was procured from nonpregnant and pregnant (days 7, 14, 17, 19, and 21 of gestation), laboring (after the first pup was delivered on day 22), and postpartum
(3 days after the delivery) rats. The uterus was excised and opened,
and the uterine horns were placed in Hanks’ balanced salt solution
(HBSS) (Gibco). After collection, samples were snap-frozen in liquid
nitrogen and stored at −80°C for RNA or protein isolation or used immediately for cell isolation. For each day of gestation, tissues were collected from six different animals and processed for different experimental
purposes.
Mouse strains
Adult C57BL/6 (wild type) (Charles River Laboratories), b-arrestin-1–
null (Arrb1−/−), b-arrestin-2–null (Arrb2−/−), and TRPV4-null (Trpv4−/−)
mice female mice were subjected to timed matings, with the morning of
vaginal plug detection designated as day 0 of pregnancy. Arrb1−/− and
Arrb2−/− mice were provided by R. J. Lefkowitz and have been described
previously (35, 36). Trpv4−/− mice were provided by W. Liedtke and have
been described previously (37).
Murine preterm labor model
In separate experiments, pregnant C57BL/6 mice were treated on D15
with either the estrogen antagonist RU-486 (150 mg, Roussel Uclaf) or
LPS (Escherichia coli 0127:B8, chromatographically pure, Sigma-Aldrich)
via the intraperitoneal route. RU-486–treated mice were then treated
with either intraperitoneal injections of normal saline (200 ml) or one
of two treatment (intraperitoneal) regimens with the selective TRPV4
channel antagonist HC 067047 (R&D Systems). One group received a
single dose of HC 067047 (20 mg/kg) and another group received HC
067047 at 10 mg/kg every 8 hours, beginning 8 hours after RU-486 administration. In the LPS experimental series, timed pregnant mice on
D15 were assigned to one of four experimental groups and given intraperitoneal injections of either (i) vehicle (saline, 200 ml), (ii) LPS (3 mg/kg)
(Sigma), (iii) LPS + a single dose of HC 067047 (20 mg/kg), or (iv) LPS +
multidose HC 067047 (10 mg/kg every 8 hours).

MATERIALS AND METHODS
Study design
We sought to determine whether the TRPV4 channel modulates uterine
contractility. To address this overall objective, we used myometrial
tissue and cells from pregnant and nonpregnant rats and mice, human
mSMCs, and in vivo studies in two separate mouse models of preterm
labor. Myometrial tissue and cells were stimulated with oxytocin, LPS,
and pharmacologic activators and antagonists of TRPV4. Myometrial
cell cytosolic calcium concentration was measured, and myometrial tone
was assessed by myography. For the in vivo studies, experimental
animals were randomly assigned to the treatment groups. A single investigator, blinded to the experimental groups, performed the data analysis
for the myography studies. Experiments were performed a minimum of
three separate times unless otherwise stated in the figure legend.

Cell isolation and primary culture of rat mSMCs
Strips of longitudinal muscle (10 to 20 mm long) were cut from the serosal
surface of the uterine horn, carefully excluding endometrium and circular
muscle, and finely chopped into 2- to 3-mm-long pieces in ice-cold HBSS
and then incubated with gentle shaking for 40 min at 37°C in 5 ml of
HBSS containing 1.5 mM CaCl2, collagenase type IA (2 mg/ml) (Sigma),
trypsin inhibitor (2 mg/ml) (soybean, type II-S, Sigma), and bovine
serum albumin (BSA) (6 mg/ml) (Sigma). The cell suspension was then
triturated 15 to 20 times, filtered through a 40-mm sterile filter, and washed
twice in minimum essential medium (MEM) (Gibco) containing 10% fetal
calf serum (FCS) by centrifugation (450g, 5 min, 20°C). The cell pellet was
suspended in MEM supplemented with 5% FCS, penicillin (25 U/ml),
and streptomycin (25 U/ml). For imaging protocols, cell solution (400 ml)
was placed on glass coverslips and cells were allowed to adhere for about
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of inflammation-induced preterm labor, TRPV4 channel antagonism
was associated with full-term pregnancy. In addition to modulating
intracellular calcium, the TRPV4 channel plays a role in regulating
the inflammatory response. Pharmacologic blockade of TRPV4 decreases inflammation in a model of arthritis (33). Activation of TRPV4
in adipocytes promotes an inflammatory phenotype, increasing the expression of numerous cytokines, chemokines, and adhesion molecules
(28). In our studies, TRPV4 blockade appeared to prolong pregnancy
more effectively in an inflammatory, as compared to endocrine, model,
suggesting that TRPV4 might modulate myometrial inflammation;
however, definitive evidence is lacking.
Data derived from calcium imaging studies, collagen gel contraction
assays, and myography also support a specific role for TRPV4. mSMC
calcium transients prompted by TRPV4 channel stimulation were
greater and more sustained in cells derived from pregnant, as opposed
to nonpregnant, rats. Experiments carried out in collagen gels using a
gain- and loss-of-function strategy demonstrated that either oxytocinor inflammation-induced mSMC contraction is contingent upon TRPV4
channel expression. Myography studies further support a central role for
the myometrial TRPV4 channel in mediating uterine contractility. In
uterine tissue with either deletion or pharmacologic inhibition of the
TRPV4 channel, the uterine contractile response to oxytocin was decreased.
Conversely, specific pharmacologic activation of TRPV4 augmented myometrial contractility. These data all point to a physiologically relevant role
for the TRPV4 channel in uterine quiescence and the uterine contractile
response to oxytocin. It is interesting to note that in Arrb1−/− and
Arrb2−/− null mice, the myometrial contractile response to oxytocin
is accentuated (31).
Strategies designed to modulate entry of extracellular Ca2+ into mSMC,
and thereby contractility, have been less than successful in preventing
or halting the progression of preterm labor thus far (34). Our studies
address the physiology, molecular expression, and protein trafficking of
the mSMC TRPV4 channel during pregnancy and thereby provide insights into the fundamental biology of pregnancy and uterine quiescence and contraction. By demonstrating that modulating TRPV4 channel
activity in the context of murine models of preterm labor can prolong
pregnancy, our data support the notion that the TRPV4 channel represents a potential therapeutic target to address, in part, preterm labor
and delivery, the primary cause of neonatal morbidity and mortality
across the world.
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1 hour, after which the coverslips were flooded with an additional 1.6 ml
of culture medium. For Western blot analysis, myocytes were seeded into
25-cm3 culture flasks. Myocytes were incubated at 37°C in a humidified
atmosphere of 95% air/5% CO2 and maintained as a primary culture
until confluent (on average, 4 days). The culture medium was changed
every 2 to 3 days. To assess the purity of myocyte cultures, we performed
immunocytochemistry with a-actin (Sigma) and calponin (Abcam)
monoclonal antibodies (see details below).

Immunofluorescent staining of myometrial tissue
Uterine tissue was obtained from pregnant and nonpregnant mice, placed
in O.C.T., and frozen. Frozen tissue sections were rehydrated and treated
for 30 min with 1× PBS/0.25% Triton X-100 solution, and subsequently
rinsed in PBS for 5 min x 2. Tissue sections were then incubated for 40 min
in undiluted Sea Block Blocking Solution (Thermo Scientific), rinsed in
PBS, and then incubated in undiluted Fc Receptor Blocker solution (Innovex Biosciences) for 30 min. After being rinsed in PBS, tissue sections
were then incubated overnight at 4°C with a primary antibody against
TRPV4 (1:300, Abcam). Sections were then washed in PBS for 3 × 10 min
and then incubated with the suitable fluorochrome-labeled secondary
antibodies: goat anti-rabbit Alexa Fluor 488 (Invitrogen/Molecular
Probes). Chromatin was counterstained with Hoechst reagent (10 mg/ml)
(Sigma-Aldrich) diluted in H2O (1:10,000). Specimens were examined
by confocal microscopy with an Olympus FV-1000 laser scanning
confocal microscope (HeNe/Ar) ×60 water immersion objective, and
images were processed with the FluoView software (Olympus). Selected
frames are representative images.
Quantitative real-time PCR
Quantitative real-time PCR (RT-PCR) was performed to determine Trpv4
gene expression at different time points during gestation in the rat uterus.
Total RNA was extracted from the frozen tissues and from the frozen
pellet of rat SMC using TRIzol (Invitrogen) according to the manufacturer’s instructions. RNA samples were column-purified using RNeasy
Mini Kit (Qiagen). After quantification, 2 mg of total RNA was used to
synthesize single-stranded complementary DNA (cDNA) using 200 IU
of SuperScript III reverse transcriptase (Invitrogen). Then, cDNA was
subjected to RT-PCR using validated primer and probe sets for TRPV4,
which were obtained from Applied Biosystems, and 18S ribosomal RNA
from IDT. Quantitative PCR was performed in the presence of either

Protein isolation from rat myometrial tissue and smooth
muscle cells
Confluent primary cultured rat mSMCs were washed with PBS. Cells
were detached from culture flasks by scraping in ice-cold PBS and
centrifuged at 4000g for 5 min at 4°C, and the pellets were snap-frozen
in liquid nitrogen and stored at −80°C until required. Myometrial
tissue was crushed in liquid nitrogen using a mortar and pestle, then
homogenized in 500 ml of lysis buffer [50 mM tris-HCl, 150 mM
NaCl, 1% deoxycholic acid, 0.1% SDS, 0.5% NP-40, Complete protease
inhibitor cocktail (Roche), 1 mM phenylmethylsulfonyl fluoride], and
centrifuged at 3000g for 10 min at 4°C. The supernatant was collected,
and protein concentrations were determined using the BCA protein
assay kit (Thermo Scientific).
Western blotting
Myometrial protein (30 mg) was denatured at 70°C for 10 min in 4× LDS
sample buffer (Invitrogen), size-separated using Novex 4-12% Bis-Tris
Mini Gels (Invitrogen), and then transferred to polyvinylidene difluoride membrane (Immobilon, Millipore). After transfer, membranes were incubated for 1 hour at room temperature in blocking
buffer (PBS-T: 0.1% Tween 20, Sigma, 5% nonfat dry milk) and subsequently incubated overnight at 4°C with the desired rabbit polyclonal
primary antibody. Primary antibodies used were TRPV4 (Alomone
Labs, 1:200), ARRB1 (BD Transduction Lab, #610550), and ARRB2
(Abcam, ab31294), which were diluted in blocking buffer. For negative
controls, membranes were incubated with primary antibodies that were
preabsorbed (1 hour, room temperature) with the respective peptides, as
recommended by the supplier. After incubation with the primary antibody or negative control, membranes were washed in PBS-T (3 × 15 min)
and then incubated for 1 hour at room temperature with horseradish
peroxidase–conjugated donkey anti-rabbit secondary antibody diluted
1:5000 in blocking buffer. Thereafter, membranes were washed in
PBS-T (3 × 15 min), and protein bands were visualized with enhanced
chemiluminescence (Pierce).
Fluorescent in situ PLA (PLA-Duolink)
To determine whether TRPV4 and ARRB2 physically interact, we used
a PLA. PLA, an antibody-based technique, is capable of visualizing
protein-protein interactions (38) and has the advantage of providing
an “in situ” snapshot of the proteins of interest. A PLA signal is generated when the distance between the two secondary antibodies is less
than 16 nm (39). Frozen uterus muscle strips were sliced (3 mm) and
placed on a glass coverslip (25 mm × 75 mm × 1 mm). PLA assay was
performed using Duolink In Situ kit (Olink Bioscience) according to
the manufacturer’s instructions. In brief, tissues were blocked and incubated with the appropriate primary antibodies (TRPV4, 1:300;
ARRB2, 1:100; Abcam) diluted in antibody diluent overnight at 4°C
in a moist chamber. Proximity ligation was then conducted in situ. We
used the Duolink II PLA Probe Anti-Rabbit PLUS, Duolink II PLA
Probe Anti-Goat MINUS, and Duolink II Detection Reagents 563 to
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Immunocytochemistry
After inhalational anesthesia (2% isoflurane), myometrial SMCs from
pregnant and nonpregnant rats were obtained and placed in primary
culture. Cells from pregnant rats were obtained at day 21 of gestation
and subsequently used for immunolocalization studies and fixed with
4% paraformaldehyde for 10 min. Rat myometrial SMCs were washed
six times with PBS, blocked for 1 hour at room temperature (blocking
buffer: 5% normal goat serum + 4% BSA in PBS containing 0.1% Triton
X-100), and subsequently incubated overnight at 4°C with the desired
rabbit polyclonal primary antibody. Primary antibody against TRPV4
(Alomone Labs, 1:200) was diluted in blocking buffer. Rat myometrial
SMCs were then washed six times with PBS containing 0.1% Triton
X-100, incubated for 1 hour at room temperature in the dark with the
mouse Alexa Fluor 488 secondary antibody (Molecular Probes), and
washed three more times with PBS. The membrane was stained with
CellMask plasma membrane stains from Invitrogen, and the slides were
mounted with Vectashield containing DAPI.

FAM (for TRPV4) or SYBR Green (for 18S) (Applied Biosystems), and
amplicon yield was monitored during cycling in an ABI PRISM 7000
Sequence Detection System (Applied Biosystems Ltd.). A comparative
Ct method (DDCt method) was applied to the raw Ct values to evaluate
relative gene expression. The expression of each TRPV gene on a specific
gestational day calculated in reference to the individual calibration curves
was normalized to the amount of ribosomal 18S mRNA.
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visualize interactions. After serial washes in buffer A (0.01 M tris,
0.15 M NaCl, and 0.05% Tween 20) and buffer B (0.2 M tris and
0.1 M NaCl) for 1 min, the slides were air-dried and mounted with the
Duolink Mounting Medium, and images of five random fields were
captured for each tissue.

Myography of mouse uterine strips
Timed-pregnant wild-type C57/B6 and Trpv4−/− mice were anesthetized
with isoflurane and euthanized before making a vertical midline abdominal incision and removing each of the two uterine horns. Uterine
horns were subsequently cut into 3-mm × 7-mm segments and placed
in a modified Krebs buffer (118 mM NaCl, 4.8 M KCl, 1.2 mM MgSO4,
1.2 mM KH2PO4, 2.5 mM CaCl2, 25 mM NaHCO3, and 11 mM glucose,
pH 7.4). Muscle segments were vertically suspended on custom-made
stainless steel hooks inside an organ bath filled with modified Krebs
buffer, maintained at 37°C, and aerated with gas containing 95% O2
and 5% CO2. The strips were allowed to equilibrate at 1.5 g of tension
for 60 min. All uterine strips demonstrated a spontaneous contraction
pattern. For the oxytocin dose-response experiments, the strips were then
stimulated with oxytocin at concentrations ranging from 1 to 1000 nM,
and the pattern of contraction in response to each dose was recorded
for 9 min. The muscle strips were washed with Krebs solution twice
and allowed to equilibrate for 3 min before the next stimulation. In
separate experiments, strips were treated with the HC 067047 compound at one of two doses before assessing the dose response to oxytocin. Strips were also treated with the TRPV4 channel agonist
GSK1016790A at concentrations ranging between 1 and 1000 nM
in the presence and absence of the HC 067047 compound. In a
separate series of experiments, muscle strips from TRPV4-null mice
were treated with increasing doses of oxytocin. Contraction tracings
were recorded using PowerLab and LabChart (ADInstruments). The
area under the curve was calculated for the final 3 min of each 9-min
contraction tracing using GraphPad Prism (GraphPad Prism for
Macintosh version 5.0; GraphPad Software). The area under the curve
for each response was then normalized to the area under the curve for
the spontaneous contraction pattern over the 5-min period that immediately preceded the challenge.

SUPPLEMENTARY MATERIALS
www.sciencetranslationalmedicine.org/cgi/content/full/7/319/319ra204/DC1
Fig. S1. TRPV4 expression is increased in pregnant human uterine tissue.
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Human uterine SMC contraction assay
Collagen gel contraction assays were performed as previously described
(40) with modification. Collagen (150 ml) was aliquoted per well of a
48-well plate. After 1 hour of polymerization, 40,000 human uterine
SMCs, transfected with either nontargeted control (NTC) siRNA or
TRPV siRNA for 48 hours, were added to each well in 300 ml of SmBM
smooth muscle basic medium (Lonza). Collagen gels were exposed to
either PBS (controls), LPS (100 ng/ml), or oxytocin (100 nM). After
incubating for 1 hour at 37°C and 5% CO2, the sides of the collagen
gels were detached from the wells with sterile 200-ml pipette tips. After
18 hours, cells in collagen-coated wells were fixed with 4% paraformaldehyde solution for 30 min, then rinsed, and stored in PBS. Experiments were done multiple times (n = 4), with triplicates for each
condition. Area of each gel was measured using the AmScope software. In brief, the cross-sectional diameter of each gel was measured
(two diameter measurements per gel sample). The following formula was
used to determine the area of a circle: (p)(r)2, where r is the radius. Mean
surface area was determined using two distinct diameter measurements.
The areas were then expressed as a percentage relative to the area of no
cell control (set at 100%) (P < 0.001).

Statistical analysis
Results are expressed as means ± SEM. Statistical significance was assessed
with Student’s t test (for normally distributed samples), Mann-Whitney
U test (for samples that were not normally distributed), and one- or twoway ANOVA where appropriate. A P value of <0.05 was taken as the
threshold for statistical significance. All experiments were repeated a
minimum of three times unless stated otherwise.
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TRPing up preterm labor
The biology of preterm labor, the leading cause of perinatal complications and deaths worldwide, is not yet
well understood, and there is no effective treatment. Ying et al. have now uncovered the role of a calcium channel
called TRPV4 (transient receptor potential vanilloid 4) in uterine contractility. The amount of TRPV4 gradually
increases throughout gestation, explaining its ability to facilitate uterine contractions at term despite maintaining
uterine quiescence earlier in pregnancy. The authors also demonstrated that blocking TRPV4 successfully
prolonged pregnancy in two mouse models of preterm labor, suggesting that it may be a viable target for
interventions to treat preterm labor in human patients.

